Literature DB >> 3157438

Immune response of mice exposed to cis-diamminedichloroplatinum.

O Bagasra, L Currao, L R DeSouza, J W Oosterhuis, I Damjanov.   

Abstract

The effects of cis-diamminedichloroplatinum (CDDP) on lymphoid organs and the immune response of young and older adult mice were studied histologically and by functionally assessing the activity of various subpopulations of immune cells. Young adult mice (6-8 weeks old) treated with 2 mg/kg CDDP mounted an enhanced splenic plaque-forming cell (PFC) response to both sheep erythrocytes, a helper T-cell-dependent antigen (HD), and pneumococcal polysaccharide type III a helper T-cell-independent antigen (HI). Older adult mice (18-22 weeks old) treated in the same way exhibited an equally enhanced PFC response to HD antigen and even a more pronounced response to HI antigen. Treatment of mice with 12 mg/kg CDDP resulted in immunosuppression. Thymus, lymph nodes, and spleen of animals treated with the higher dose of CDDP showed a marked cell depletion from both T and B areas, confirming that the immunosuppression was due to an indiscriminate elimination of both T and B lymphocytes. The immunosuppression and the cell depletion from lymphoid organs were more pronounced in younger mice. Thus, the effects of CDDP on the lymphoid organs and the immune response depend both on the age of the animals and on the dose of the drug. CDDP given in small doses enhances the PFC response, whereas a reduced PFC response is obtained following high-dose treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157438     DOI: 10.1007/bf00199723

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  26 in total

1.  The effect of Bordetella pertussis on the antibody response in mice to type III pneumococcal polysaccharide.

Authors:  A S Kong; S I Morse
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

2.  Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response.

Authors:  H C Morse; B Prescott; S S Cross; P W Stashak; P J Baker
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

3.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

4.  The mechanism of action of antitumor platinum compounds.

Authors:  J J Roberts; A J Thomson
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1979

5.  Enhanced immune responsiveness to a thymus-independent antigen early after adult thymectomy: evidence for short-lived inhibitory thymus-derived cells.

Authors:  R S Kerbel; D Eidinger
Journal:  Eur J Immunol       Date:  1972-04       Impact factor: 5.532

6.  Suppression of lymphocyte blastogenesis in man following cis-platinous diamminodichloride administration.

Authors:  A Khan; J M Hill
Journal:  Proc Soc Exp Biol Med       Date:  1973-01

7.  Changes in suppressor, helper, and B-cell functions in aging mice.

Authors:  J J Liu; M Segre; D Segre
Journal:  Cell Immunol       Date:  1982-01-15       Impact factor: 4.868

Review 8.  Age influence on the immune system.

Authors:  T Makinodan; M M Kay
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

Review 9.  Immunologic complementation between thymus and marrow cells--a model for the two-cell theory of immunocompetence.

Authors:  H N Claman; E A Chaperon
Journal:  Transplant Rev       Date:  1969

10.  The effects of dichloro-trans-dihydroxy-bis-isopropyl-amine-platinum IV on the primary cell-mediated cytotoxic response.

Authors:  E Schlaefli; M J Ehrke; E Mihich
Journal:  Immunopharmacology       Date:  1983-08
View more
  4 in total

1.  Functional analysis of lymphocytes subpopulations in experimental cocaine abuse. I. Dose-dependent activation of lymphocyte subsets.

Authors:  O Bagasra; L Forman
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

2.  The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells.

Authors:  J L Collins; M S Kao
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: interim results of a phase I trial.

Authors:  J T Rubin; M T Lotze; D Rosenfelder; A Brumfield; R Howells; R Schwartz; S Sylvestri; J Sammon; K Bron; P Orens
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

4.  The effectiveness of cis-platinum, cyclophosphamide and melphalan in treating disseminated tumor cells in mice.

Authors:  A Kanclerz; J D Chapman
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.